Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to register a CAGR of 30.1% during the forecast period (2018 - 2024) - KBV Research

12-11-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, published by KBV research, the Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market would witness market growth of 30.1% CAGR during the forecast period (2018 – 2024).

The Germany Market held the largest share in the Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017. The France market is expected to witness a significant CAGR during the forecast period (2018 – 2024).

The Suprachoroidal Space segment is growing at a significant pace in the Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market during (2018-2024). However, Trabecular Meshwork segment dominated the market in 2017 and is expected to grow at CAGR of 29.5% over the forecast period.

Eye Hospitals among the End Users would dominate the Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User by 2024; thereby, growing at a CAGR of 29.6% during (2018-2024). Additionally, Ophthalmology Clinics is growing at significant pace during the forecast period.

Full Report: https://www.kbvresearch.com/europe-minimally-invasive-glaucoma-surgery-migs-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.

Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

By Surgery